Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
Date:3/11/2011

160;Acquired technology & other non-current assets

18,02319,560Total assets

$ 266,362$ 236,278Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$   10,680$   15,884  Total deferred revenues

48,0774,086  Total derivative liabilities

2,2716,642  Total note payable to Siegfried

10,3619,143  Total note payable to Deerfield **

37,77747,906  Total lease financing obligations & other long-term liabilities

77,18178,050  Total stockholders' equity

80,01574,567Total liabilities & stockholders' equity

$ 266,362$ 236,278* The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of December 31, 2009 and from the unaudited financial statements as of December 31, 2010.* * The outstanding principal balance of the note payable to Deerfield was $60.0 million and $90.0 million at December 31, 2010 and December 31, 2009, respectively.
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... 29, 2015 The Parenteral Drug Association is ... Board of Professional Engineers and Land Surveyors ... to professional engineers for continuing professional competency (CPC) credits. ... value and quality of PDA,s professional education offerings," said ... and hands-on professional training at the Training and Research ...
(Date:6/29/2015)... EASTON, Mass. , June 29, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale ... preparation solutions to the worldwide life sciences industry, ... the Institute of Molecular Systems Biology, ETH Zurich, ... proteomic profiling and classification of prostate cancer tissue ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Feb. 21, 2012 A collaboration between NineSigma and ... advance HIV vaccine research by identifying new approaches to ... provider of innovation services , NineSigma has connected ... and helped it identify two scientists who will receive ...
... #8116 -- Precyse, a leader in health information ... HIMSS 2012 Annual Conference and Exposition that the ... improvements in revenue cycle workflow, coding accuracy, and ... adopting Precyse,s integrated health information management (HIM) and ...
Cached Medicine Technology:IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 3IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 4Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 2Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 3Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 4
(Date:6/30/2015)... , ... June 30, 2015 , ... Scott Purdy, the ... name to Provider XO. Scott Purdy stated that the XO stands for eXtra Operability ... that automate the workflow processes of the Revenue Cycle. , Provider XO, based ...
(Date:6/29/2015)... FL (PRWEB) , ... June 30, 2015 , ... Sublime ... special 50% Off offer. The oil, ideal for natural skincare and even culinary ... and easy way is something most people desire, and Oil Pulling can accomplish this. ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down ... at Soldier Field over the 4th of July weekend. Concertgoers can add promo/coupon ... have only recently caught on to their innovative sound, will not want to miss ...
(Date:6/29/2015)... ... June 29, 2015 , ... An upcoming documentary for ... James Earl Jones will offer a fresh perspective on conflict in sports with ... is one of several thought leaders from around the sports industry that will discuss ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... group series as part of its support program. This discussion series is part ... and other support services to those affected by mesothelioma. , The six week ...
Breaking Medicine News(10 mins):Health News:Dephinitive Systems Is Getting a New Name 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3
... caused by injury to the peripheral nerves in diseases ... motion disorders and trauma, and does not respond well ... rodents by scientists from the University of California, San ... a protein called LRP1 may help to ease neuropathic ...
... CARROLLTON, Texas, Dec. 5 Fry Construction, ... facilities, has,been recently featured as a success "case ... The feature, entitled "Specialization Leads,to Success," is an ... the,story behind its incomparable success in the industry., ...
... Inc., a leader in,applying integrated human biology systems ... entered into a collaboration agreement with,UCB, a global ... will apply its BioMAP(R) Systems to evaluate a,number ... support of target,differentiation, lead development, and drug candidate ...
... Nexia Holdings, Inc.,(OTC Bulletin Board: NEXA), a diversified ... and real estate, issued the following,update to shareholders from ... I am pleased to address shareholder concerns about the ... I anticipate a 1-for-100 split to be effective ...
... New Guide on http://www.thepill.com , RARITAN, N.J., Dec. ... how much do Modern Girls really know about this birth,control ... http://www.prnewswire.com/mnr/ortho/29291/ , Since its development more than ... used birth control method. Although more than 80 percent,of American ...
... - People who believe,in themselves can raise their aspirations, ... things by watching others do them., So says ... psychology who has won the 2008 University of Louisville,Grawemeyer ... Grawemeyer,psychology prize from among 31 nominations from five countries., ...
Cached Medicine News:Health News:Protein found that may provide relief from neuropathic pain 2Health News:Fry Construction Is Featured in Key Industry Publication 2Health News:BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB 2Health News:Nexia Holdings CEO Issues Update to Shareholders 2Health News:Nexia Holdings CEO Issues Update to Shareholders 3Health News:Nexia Holdings CEO Issues Update to Shareholders 4Health News:Video: What 'Modern Girls' Should Know About the Pill 2Health News:Video: What 'Modern Girls' Should Know About the Pill 3Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2
The 16 liter Laparoscopy Insufflator combines high safety and precise pressure control with simple operation....
The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
... GenoID's kit is the first commercially ... for clinical diagnostic use. , ,The ... and 5 low-risk genotypes of HPV ... PCR technology but simplifying the process ...
... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ...
Medicine Products: